BNP Paribas Financial Markets’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $169K | Buy |
|
|||||
|
2022
Q4 | $100K | Buy |
|
|||||
|
2022
Q3 | $46.5K | Buy |
|
|||||
|
2022
Q2 | $27.6K | Buy |
|
|||||
|
2022
Q1 | $30.5K | Sell |
|
|||||
|
2021
Q4 | $111K | Buy |
|
|||||
|
2021
Q3 | $69.9K | Buy |
|
|||||
|
2021
Q2 | $22.5K | Sell |
|
|||||
|
2021
Q1 | $80.4K | Buy |
|
|||||
|
2020
Q4 | $21.9K | Sell |
|
|||||
|
2020
Q3 | $30.5K | Buy |
|
|||||
|
2020
Q2 | $6.03K | Sell |
|
|||||
|
2020
Q1 | $24K | Buy |
|
|||||
|
2019
Q4 | $34K | Buy |
|
|||||
|
2019
Q3 | $8.62K | Sell |
|
|||||
|
2019
Q2 | $12.8K | Sell |
|
|||||
|
2019
Q1 | $20.7K | Buy |
|
|||||
|
2018
Q4 | $1.34K | Sell |
|
|||||
|
2018
Q3 | $4.13K | Sell |
|
|||||
|
2018
Q2 | $7.88K | Sell |
|
|||||
|
2018
Q1 | $70.1K | Buy |
|
|||||
|
2017
Q4 | $35.2K | Buy |
|
|||||
|
2017
Q3 | $9.8K | Sell |
|
|||||
|
2017
Q2 | $9.34K | Buy |
|